A detailed history of Russell Investments Group, Ltd. transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 2,849 shares of PLSE stock, worth $44,871. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,849
Previous 2,877 0.97%
Holding current value
$44,871
Previous $32,000 53.13%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.83 - $21.83 $303 - $611
-28 Reduced 0.97%
2,849 $49,000
Q2 2024

Aug 08, 2024

BUY
$6.69 - $14.54 $10,235 - $22,246
1,530 Added 113.59%
2,877 $32,000
Q1 2024

May 08, 2024

SELL
$7.8 - $11.02 $436 - $617
-56 Reduced 3.99%
1,347 $11,000
Q4 2023

Feb 05, 2024

BUY
$3.85 - $12.84 $5,401 - $18,014
1,403 New
1,403 $17,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $585M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.